cytarabine has been researched along with Hyperammonemia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Huitema, ADR; Otten, HM; Verkerk, K | 1 |
Akaihata, M; Hosoya, M; Ito, M; Kikuta, A; Kobayashi, S; Mochizuki, K; Ohara, Y; Sano, H; Waragai, T | 1 |
Boeck, S; Braess, J; Christ, B; Hausmann, A; Hiddemann, W; Metzeler, KH; Ostermann, H; Parhofer, KG; Stemmler, HJ | 1 |
1 review(s) available for cytarabine and Hyperammonemia
Article | Year |
---|---|
Idiopathic hyperammonemia (IHA) after dose-dense induction chemotherapy for acute myeloid leukemia: Case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Cytarabine; Female; fms-Like Tyrosine Kinase 3; Humans; Hyperammonemia; Leukemia, Myeloid, Acute; Middle Aged; Mitoxantrone; Mutation; Nuclear Proteins; Nucleophosmin | 2009 |
2 other study(ies) available for cytarabine and Hyperammonemia
Article | Year |
---|---|
Idiopathic hyperammonemic encephalopathy secondary to gemcitabine-cisplatin treatment.
Topics: Antineoplastic Agents; Asparaginase; Brain Diseases; Cisplatin; Cytarabine; Deoxycytidine; Fluorouracil; Gemcitabine; Humans; Hyperammonemia; Neurotoxicity Syndromes | 2022 |
Idiopathic Hyperammonemia That Developed During Initial Treatment With Steroid in a Patient With Newly Diagnosed Leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Humans; Hydrocortisone; Hyperammonemia; Lactulose; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis | 2015 |